about
Characteristics and risk factors for 28-day mortality of hospital acquired fungemias in ICUs: data from the EUROBACT studyDiagnosis and management of temperature abnormality in ICUs: a EUROBACT investigators' survey.Quality of life in patients aged 80 or over after ICU discharge.A multifaceted program for improving quality of care in intensive care units: IATROREF study.Mortality associated with timing of admission to and discharge from ICU: a retrospective cohort study.Outcome of ICU patients with Clostridium difficile infection.Antimicrobial stewardship of β-lactams in intensive care units.Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial.A Systematic Review of the Definitions, Determinants, and Clinical Outcomes of Antimicrobial De-escalation in the Intensive Care Unit.Reappraisal of visiting policies and procedures of patient's family information in 188 French ICUs: a report of the Outcomerea Research Group.The ADMIN-ICU survey: a survey on antimicrobial dosing and monitoring in ICUs.ICU physician-based determinants of life-sustaining therapy during nights and weekends: French multicenter study from the Outcomerea Research Group.Perceptions of a 24-hour visiting policy in the intensive care unit.Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome.The ETHICA study (part II): simulation study of determinants and variability of ICU physician decisions in patients aged 80 or over.Survey of caregiver opinions on the practicalities of family-centred care in intensive care units.Piperacillin-tazobactam as alternative to carbapenems for ICU patients.Attributable mortality of ventilator-associated pneumonia: respective impact of main characteristics at ICU admission and VAP onset using conditional logistic regression and multi-state models.Blood glucose changes and adjustments of diet and insulin doses in type 1 diabetic patients during scuba diving (for a change in French regulations).Long-term outcome of iatrogenic gas embolism.Pulmonary zygomycosis in solid organ transplant recipients in the current era.[Does red blood cell storage time still influence ICU survival?].Opinions of families, staff, and patients about family participation in care in intensive care units.Neurologic complications and outcomes of infective endocarditis in critically ill patients: the ENDOcardite en REAnimation prospective multicenter study.Systemic antifungal therapy in critically ill patients without invasive fungal infection*.Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study.Selected Medical Errors in the Intensive Care UnitAre new gentamicin dosing guidelines suitable for achieving target concentrations in patients with sepsis and septic shock?The Effect of ICU Diaries on Psychological Outcomes and Quality of Life of Survivors of Critical Illness and Their RelativesHyperbaric oxygen treatment for the management of radiation-induced xerostomiaAudit of practice in Australasian hyperbaric units on the incidence of central nervous system oxygen toxicityQuelle définition et quelle stratification de la désescalade antibiotique ?Les caractéristiques des réanimateurs ont-elles un rôle dans l’intensité thérapeutique des patients admis durant les périodes de garde ou les week-end ? Étude multicentrique expert-ICUEvaluation of the Febrile Patient in the ICUAntibiothérapie des états infectieux gravesAntimicrobial de-escalation as part of antimicrobial stewardship in intensive care: no simple answers to simple questions-a viewpoint of expertsAntimicrobial Stewardship in Hematological Patients at the intensive care unit: a global cross-sectional survey from the Nine-i Investigators NetworkAntimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill PDoes intermittent pneumatic compression PREVENT deep vein thrombosis in the ICU?Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure: the DIANA study
P50
Q31054881-690E7053-5369-4356-ADB9-FDCF95F8298CQ33754287-495030A0-5A65-468B-9442-B5F7C0C4B67DQ33873358-287DAC44-6194-4031-9E00-97D22C3BA08CQ34036792-01FCA0FE-F899-4F14-84E8-59DCAB605298Q34083153-025EF9E2-3E57-444B-A730-BF0C8134813FQ36902726-92122ECC-58EC-427E-996B-35B1249FD429Q38198157-CF62C9EB-9A82-405B-988B-97DAD8CB0E39Q38376133-1DBCCD71-7D2F-4B9C-A426-854C53DE7C85Q38679343-624525E5-998F-44AA-B1A6-01E3A88CB8DBQ39448561-ACE9DEA9-54F0-49AC-8352-B7AB87BA85CBQ41110594-7B1A37F8-9C94-44CA-98BA-E0B0B66D0F89Q42201742-1D86B9B2-B351-4428-BB46-51DF3D73DA2EQ42640179-C086DB5B-B51E-4448-AB6B-27C347C3BC3AQ43297767-F7F2723A-92A3-40CC-ABE5-1F8B8F13CE5FQ43649386-DF50DC86-3D63-4B9E-9AD6-81013FBF5475Q44483653-A0DA6E35-9917-406F-A653-5220C0D0A9D4Q45711115-058D202C-267F-49D9-AF35-D6C57F3D7BFFQ46249372-00B1B0BC-860F-4ECA-8C21-CFFA3BA1EB75Q46549391-A4B0C1E4-45A3-4E96-B5DE-95F48CB2E6C4Q48276051-D910F907-33DA-4567-A8B3-0AE60BF72DEDQ48485460-BC1BC5DF-FECD-438D-A19D-9E8832E1D7C0Q50636747-2AA5D485-2CEC-4380-BE60-115B5FFC1924Q50694628-68905238-04EE-4198-8E2D-73EFDF015E6FQ51052859-C06CFFB0-19B0-4D47-A58A-8415C71F86D3Q51177612-2FD55B9E-4BCE-4C67-94FE-BC74B7FABA1CQ53123244-BA3E2BC8-5D4C-4280-B295-ABB4B061C224Q56968122-847CD7E5-7CA6-414E-861C-3129AC52DC58Q64129080-AB8A1476-5014-471B-AF7F-BD8A5EAF9C5BQ64134371-D618ACB1-FCAD-4837-BE37-233F91E1CCD7Q64134376-EDBBDB76-64C7-48F3-8B71-07A7872D56D2Q64134382-CE700642-9EF9-4933-BC78-F90DA385ADFFQ64134388-DCC28DBE-8702-4942-8EBB-146829AFAAF6Q64134393-E246470E-C613-44D5-BC2F-F2D75A5D899DQ64134400-FED9E50F-0811-42E1-B891-E6E6B89CE730Q64134408-904C4828-AD01-4CE8-B46E-1CA1DB05CD54Q89561887-2D24C5A2-6B4E-41AA-9358-DF6741CEC048Q91212267-D77510AB-C94C-427E-99A0-934103D7B4A3Q91536704-BD10A281-1EA8-40F0-AAF1-9866E984DDFCQ92489937-8EC9BB08-5C73-470C-B494-A9D468269AB0Q96231998-F12A13A7-2766-4550-801B-0AA57D3463FF
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Alexis Tabah
@ast
Alexis Tabah
@en
Alexis Tabah
@es
Alexis Tabah
@nl
type
label
Alexis Tabah
@ast
Alexis Tabah
@en
Alexis Tabah
@es
Alexis Tabah
@nl
prefLabel
Alexis Tabah
@ast
Alexis Tabah
@en
Alexis Tabah
@es
Alexis Tabah
@nl
P106
P21
P31
P496
0000-0003-3513-2778